TipRanks
Go Ultimate55% OFF

ImmuPharma (IMM) Income Statement

ImmuPharma Income Statement

Last quarter (Q2 2026), ImmuPharma's total revenue was $0.00. In Q2, ImmuPharma's net income was $-4.70M. See ImmuPharma’s key income statements, including revenue, expenses, profit, and income.

Income Statement
Income StatementDec 25Dec 24Dec 23Dec 22Dec 21
$ 0.00$ 0.00$ 0.00$ 0.00$ 118.35K
$ -35.30K$ -63.88K$ -37.61K$ -118.00K$ 118.35K
$ 2.51M$ 2.67M$ 3.06M$ 2.91M$ 6.71M
Depreciation and Amortization$ 35.30K$ 63.88K$ 37.61K$ 117.56K$ 114.12K
$ -2.51M$ -2.61M$ -3.02M$ -2.91M$ -8.70M
$ -2.54M$ -2.68M$ -3.06M$ -3.03M$ -6.59M
$ 370.56K$ -104.00K$ -356.00K$ -1.43M$ -2.35M
$ -2.17M$ -2.78M$ -3.42M$ -4.46M$ -8.94M
$ -1.81M$ -2.48M$ -2.92M$ -3.81M$ -8.17M
Per Share Metrics
Basic EPS$ -0.00$ -0.01$ -0.01$ -0.01$ -0.03
Diluted EPS$ -0.00$ -0.01$ -0.01$ -0.01$ -0.03
Weighted Average Shares Outstanding490.59M413.92M360.71M302.91M251.16M
Weighted Average Shares Outstanding (Diluted)490.59M416.44M362.00M302.91M251.16M

Currency in GBP

ImmuPharma Earnings and Revenue History

-10M-5M05M-10000 %-7500 %-5000 %-2500 %EarningsProfit Margin201720182019202020212022202320242025RevenueEarningsProfit Margin